• ADTRAN, Inc. (NASDAQ:ADTN) reported Q1 EPS of $0.52, ahead of the Zacks Consensus Estimate for $0.47 per share. Revenue for the quarter increased 30% year-over-year to $165.52 million, beating the Zacks Consensus Estimate for $163.0 million
• JPMorgan Chase & Co (NYSE:JPM) reported Q1 EPS of $1.28, ahead of the Zacks Consensus Estimate of $1.15 per share. Revenues for the quarter were $25.22 billion, above the Zacks Consensus Estimate of $25.406 billion
• Mesabi Trust’s (NYSE:MSB) shares fell 7.87% after the company reported its plans to cut dividends. The company is an owner of mining rights in parts of Minnesota
• Analysts at Deutsche Bank initiated coverage of drug maker Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) with a “Buy” rating
• Maker of computer networking products Riverbed Technology, Inc.’s (NASDAQ:RVBD) shares rose 12.35% to $34.74 after the company projected first-quarter earnings above expectations
• Citigroup Inc. (NYSE:C) upgraded drug company GTx, Inc. (NASDAQ:GTXI) from “Hold” to “Buy” rating
• Oil and gas producer CAMAC Energy Inc. (AMEX:CAK) said a report found that the company may be able to recover more crude than previously estimated from an area off Nigeria
• Share prices of natural gas firm Eagle Rock Energy Partners LP (NASDAQ:EROC) gained 12.90% to close at $11.55 after it said it would acquire CC Energy II LLC
• Silgan Holdings Inc. (NASDAQ:SLGN) announced its plans to acquire its rival supplier of consumer-goods packing products Graham Packaging Co.’s (NYSE:GRM), including its debt, for a deal worth $4.1 billion
ADTRAN INC (ADTN): Free Stock Analysis Report
CITIGROUP INC (C): Free Stock Analysis Report
EAGLE ROCK EGY (EROC): Free Stock Analysis Report
GRAHAM PACKAGNG (GRM): Free Stock Analysis Report
GTX INC (GTXI): Free Stock Analysis Report
JPMORGAN CHASE (JPM): Free Stock Analysis Report
REGENERON PHARM (REGN): Free Stock Analysis Report
RIVERBED TECH (RVBD): Free Stock Analysis Report
SILGAN HOLDINGS (SLGN): Free Stock Analysis Report
Zacks Investment Research
